Venous Thrombosis, Thrombophilia & APS Flashcards
Compare an arterial vs venous thrombus
Arterial - platelet rich thrombus
Venous - fibrin rich thrombus
Where does a venous thrombus usually form
In the venous valve pockets
(& other sites of stasis)
Using Virchow’s triad, list risk factors for venous thrombosis
Stasis
- Left ventricular dysfunction
- Immobility (e.g. trauma, surgery, long flights) or paralysis
- Venous obstruction (e.g. tumour, obesity, pregnancy, age)
- Venous insufficiency/ varicose veins
Endothelial (valve) damage
- Venous valvular damage (from previous DVT/PE)
- Age
- Indwelling catheter
Hyper-coagulability
- Oestrogen therapy
- Pregnancy, peripartum
- Malignancy, sepsis/infection, trauma/surgery
- Thrombophilia
Malignancy, infection, trauma, surgery, pregnancy, oestrogen therapy etc can cause hypercoagulability. Why is this?
They are associated with release of tissue factor
They are also associated with increased VWF & factor VIII
What is thrombophilia & what are the 4 potential mechanisms for thrombophilia
- Familial or acquired disorder
- of haemostatic mechanisms
- that predispose to thrombosis
4 mechanisms
- Increased platelet coagulation
- Increased fibrin coagulation
- Decreased fibrinolytic activity
- Decreased anti-coagulant activity
What is hereditary thrombophilia and what are the 5 most common types/causes
- Factor V Leiden (protein C can’t inhibit factor V/Xa)
- Prothrombin 20210 mutation (increased prothrombin)
- Antithrombin deficiency
- Protein C deficiency
- Protein S deficiency
When would you consider screening for hereditary thrombophilia
Recurrent venous thrombosis
Unusual venous thrombosis
<45 yrs old venous thrombosis
Family history of venous thrombosis
Hereditary thrombophilia management
- Advice on avoiding risk
- Short term prophylaxis during periods of known risk
- Short term anticoagulation to treat thrombotic events
- Long term anticoagulation if recurrent thrombotic events
One cause of acquired thrombophilia is anti-phospholipid antibody syndrome, what is this?
- Autoimmune disorder
- Anti-phospholipid antibodies
- Activation of primary & secondary haemostasis
What is APS associated with
SLE (& other rheumatic or autoimmune conditions)
APS clinical presentation
- Arterial (TIA, MI, stroke) & venous (DVT, PE) thrombosis
- Pulmonary hypertension (due to recurrent PE)
- Sterile (libman-sacks) valvular endocarditis
- Miscarriage (recurrent early or late spontaneous foetal loss)
- Mild thrombocytopenia
- Migraine
- Livedo reticularis (capillary blood clot)
APS diagnostic investigations
One of the following on two occasions 12 weeks apart:
- Anti-cardiolipin
- Anti-β2-GPI antibodies
- Positive lupus anticoagulation assay
APS FBC & clotting screen findings
- FBC - thrombocytopenia
- Clotting screen - prolongation of APTT
APS management
Antibodies & one thrombotic episode
- acute LMWH then warfarin or aspirin prophylaxis
Antibodies but no thrombotic episode
- no anti-coagulation
During pregnancy in patients with recurrent miscarriage
- LMWH & aspirin
Describe APS pathophysiology
- Antiphospholipid antibodies bind to phospholipids like cardiolipin and blood proteins like βGPI (that bind to anionic phospholipids).
- This disrupts the membrane of endothelial cells which then activates haemostasis (thrombosis).
- This also affects platelets, causing them to clump together and also causing them to decrease in numbers (thrombocytopenia).
- This also reduces the availability of phospholipids, which prolongs the time it takes for blood to clot (prolonged APTT).
- This also damages the heart valves (Libman-sacks (sterile) endocarditis)